Fanconi anemia pathway and its relationship with cancer

Chenchen Dan , Hongjing Pei , Buzhe Zhang , Xuan Zheng , Dongmei Ran , Changzheng Du

Genome Instability & Disease ›› 2021, Vol. 2 ›› Issue (3) : 175 -183.

PDF
Genome Instability & Disease ›› 2021, Vol. 2 ›› Issue (3) : 175 -183. DOI: 10.1007/s42764-021-00043-0
Review Article

Fanconi anemia pathway and its relationship with cancer

Author information +
History +
PDF

Abstract

Fanconi Anemia (FA) is a rare inherited hematological disease, caused by mutations in genes involved in the DNA interstrand crosslink (ICL) repair. Up to date, 22 genes have been identified that encode a series of functionally associated proteins that recognize ICL lesion and mediate the activation of the downstream DNA repair pathway including nucleotide excision repair, translesion synthesis, and homologous recombination. The FA pathway is strictly regulated by complex mechanisms such as ubiquitination, phosphorylation, and degradation signals that are essential for the maintenance of genome stability. Here, we summarize the discovery history and recent advances of the FA genes, and further discuss the role of FA pathway in carcinogenesis and cancer therapies.

Cite this article

Download citation ▾
Chenchen Dan, Hongjing Pei, Buzhe Zhang, Xuan Zheng, Dongmei Ran, Changzheng Du. Fanconi anemia pathway and its relationship with cancer. Genome Instability & Disease, 2021, 2(3): 175-183 DOI:10.1007/s42764-021-00043-0

登录浏览全文

4963

注册一个新账户 忘记密码

References

Funding

SUST university grant(Y01416218)

AI Summary AI Mindmap
PDF

142

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/